India’s drug regulator has not cleared the application of Dr Reddy’s Laboratories seeking approval to market the Sputnik V Covid-19 vaccine, citing lack of data.from Stocks-Markets-Economic Times https://ift.tt/3dL6nF8
Stocks in the news: Nureca, Dr Reddy's Labs, Affle India, Max Financial and HGS
India’s drug regulator has not cleared the application of Dr Reddy’s Laboratories seeking approval to market the Sputnik V Covid-19 vaccine, citing lack of data.from Stocks-Markets-Economic Times https://ift.tt/3dL6nF8
Related Posts:
US Fed keeps interest rates near zero, Jerome Powell says risks to outlook remain intact- Stocks in focus: Biocon, Tata Communications, ONGC and more
- Biocon Q4 results: Net profit grows 105% on strong biosimilar business growth
- SGX Nifty jumps 143 points; here's what changed for market while you were sleeping
- Sebi deepens fund managers' skin in the game
0 Comments:
Post a Comment